Subject category:
Economics, Politics and Business Environment
Published by:
IBS Case Development Center
Length: 7 pages
Data source: Published sources
Topics:
European Union (EU); Lipitor; Drug price regulations in Europe; Health care systems in Europe; National Health Services in Europe; Reference pricing; Profit regulation; Product price controls; New molecular entities (NMEs); Research and development (R&D) investments in European drug industry; Pfizer Inc; Tamoxifen; Novartis; Monopsonist price setter; Drug price distortions
Share a link:
https://casecent.re/p/19145
Write a review
|
No reviews for this item
This product has not been used yet
Not yet registered with us?
Register today to place orders, create search alerts, submit cases to us ... and much more.
Registered educators and trainers, and their support staff, can also access preview copies, instructor materials and see product reviews and usage.